These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 29027620

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE, Farrington CA, Wall GC, Belz MM.
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [Abstract] [Full Text] [Related]

  • 3. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP.
    Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619
    [Abstract] [Full Text] [Related]

  • 4. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov 07; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 5. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
    Watson M, Abbott KC, Yuan CM.
    Clin J Am Soc Nephrol; 2010 Oct 07; 5(10):1723-6. PubMed ID: 20798253
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Secondary prevention of hyperkalemia with sodium polystyrene sulfonate in cardiac and kidney patients on renin-angiotensin-aldosterone system inhibition therapy.
    Chernin G, Gal-Oz A, Ben-Assa E, Schwartz IF, Weinstein T, Schwartz D, Silverberg DS.
    Clin Cardiol; 2012 Jan 07; 35(1):32-6. PubMed ID: 22057933
    [Abstract] [Full Text] [Related]

  • 9. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate.
    Nguyen T, Ondrik D, Zhufyak O, To W, He S.
    JAAPA; 2015 Mar 07; 28(3):41-5. PubMed ID: 25710403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Asymptomatic Cecal Perforation in a Renal Transplant Recipient After Sodium Polystyrene Sulfonate Administration.
    Singla M, Shikha D, Lee S, Baumstein D, Chaudhari A, Carbajal R.
    Am J Ther; 2016 Mar 07; 23(4):e1102-4. PubMed ID: 25415544
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K, Flynn J, Okamura D, Zhou L.
    J Ren Nutr; 2013 Sep 07; 23(5):333-9. PubMed ID: 23707305
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.